M&A Deal Summary |
|
|---|---|
| Date | 2025-02-06 |
| Target | Altus Power |
| Sector | Renewable Energy |
| Buyer(s) | TPG |
| Deal Type | Going Private |
| Deal Value | 2.2B USD |
| Advisor(s) | Moelis & Co. (Financial) Latham & Watkins (Legal) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 296.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.
| DEAL STATS | # |
|---|---|
| Overall | 441 of 451 |
| Sector: Renewable Energy M&A | 8 of 8 |
| Type: Going Private M&A Deals | 37 of 39 |
| State: Connecticut M&A | 5 of 5 |
| Country: United States M&A | 290 of 298 |
| Year: 2025 M&A | 2 of 12 |
| Size (of disclosed) | 38 of 113 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-04 |
Elevated Materials
Santa Clara, California, United States Elevated Materials is at the forefront of battery innovation, delivering ultra-thin, uniform lithium films through their advanced vapor deposition process. Its lithium films unlock battery performance, enhancing energy density, lifespan and charge rates. Elevated Materials was founded in 2025 and is based in Santa Clara, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-03-31 |
Novotech
Sydney, Australia Novotech is a full-service contract research organization (CRO) that provides biotech and small- to mid-sized pharmaceutical companies. Novotech was founded in 1997 and is headquartered in Sydney, New South Wales. |
Sell | - |